Participation in research and access to experimental treatments by HIV-infected patients

New England Journal of Medicine

Volumn 346, Issue 18, 2002, Pages 1373-1382

  Gifford, Allen L ^a,b,c   Cunningham, William E ^d   Heslin, Kevin C ^d   Andersen, Ron M ^d   Nakazono, Terry ^d   Lieu, Dale K ^a,b,c   Shapiro, Martin F ^d,e   Bozzette, Samuel A ^a,b,c,e  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

ADULT; ARTICLE; CLINICAL RESEARCH; DRUG EFFECT; ETHNIC GROUP; FEMALE; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; RESEARCH; SOCIOECONOMICS; UTILIZATION REVIEW;

BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL APPROACH/SOURCE; RESEARCH SUBJECTS; THERAPEUTIC RESEARCH;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ATTITUDE TO HEALTH; CLINICAL TRIALS; DRUG EVALUATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; INSURANCE, HEALTH; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; RESEARCH SUBJECTS; THERAPEUTIC HUMAN EXPERIMENTATION; UNITED STATES;

EID: 0037007681     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMsa011565     Document Type: Article

References (48)

1. NIH guidelines on the inclusion of women and minorities as subjects in clinical research
2. The challenge of minority recruitment in clinical trials for AIDS
3. HIV infection in women in the United States: Status at the Millennium
4. Influence of race or ethnicity on pharmacokinetics of drugs
5. Zidovudine side effects as reported by black, Hispanic, and white/non-Hispanic patients with early HIV disease: Combined analysis of two multicenter placebo-controlled trials
6. Zidovudine: Does it work for everyone?
7. Selection bias and treatment heterogeneity in clinical trials
8. Expanded access for HIV treatments: The VIDEX (ddI) experience and future plans
9. Salvage antiretroviral therapy
10. AIDS - Challenges to basic and clinical biomedical research
11. Differences in participation in experimental drug trials among persons with AIDS
12. Participation in clinical trials among women living with HIV in Canada
13. Race, gender, drug use, and participation in AIDS clinical trials: Lessons from a municipal hospital cohort
14. Clinical research and drug development of antivirals in HIV: An industry perspective
15. Expanded distribution of an investigational drug in parallel with ongoing controlled clinical trials: The didanosine model
16. The care of HIV-infected adults in the United States
17. National probability samples in studies of low-prevalence diseases. II. Designing and implementing the HIV Cost and Services Utilization Study sample
18. Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study
19. National probability samples in studies of low-prevalence diseases. I. Perspectives and lessons from the HIV Cost and Services Utilization Study
20. Technical notes
21. The relationship between method of physician payment and patient trust
22. Health care involvement preferences and social-emotional recovery of male coronary-artery-bypass patients
23. Assessment of preferences for self-treatment and information in health care
24. AIDS cases by sex, age at diagnosis, and race/ethnicity, reported through December 1999, United States
25. Inference from complex samples
26. The didanosine Expanded Access Program: Safety analysis
27. Representation of African-Americans, hispanics, and whites in National Cancer Institute cancer treatment trials
28. Do blacks believe that HIV/AIDS is a government conspiracy against them?
29. Attitudes and beliefs of African Americans toward participation in medical research
30. Factors affecting African-American participation in AIDS research
31. Evaluation of a video-supplement to informed consent: Injection drug users and preventive HIV vaccine efficacy trials
32. Effects of two formats of informed consent on knowledge amongst persons with advanced HIV disease in a clinical trial of didanosine
33. Representation of American blacks in clinical trials of new drugs
34. Subject selection biases in clinical trials: Data from a multicenter schizophrenia treatment study
35. Clinical trial enrollers vs. nonenrollers: The Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project
36. Reasons for sex-specific and gender-specific study of health topics
37. Provider attitudes regarding participation of women and persons of color in AIDS clinical trials